Discrete choice experiment demonstrated that number of doses was the most important attribute driving patient…
CAMBRIDGE, Mass., March 11, 2022 (GLOBE NEWSWIRE) — Walden Biosciences, Inc. (Walden), a private, venture-backed…
Unique platform offering capabilities from vector design and process development through to clinical trials is…
UPPSALA, SWEDEN – LIDDS AB (publ)’s (“LIDDS” or the “Company”) Extraordinary General Meeting was held…
Momentum Building for Novel Vazalore® Liquid-Filled Aspirin Capsules Total Net Sales of $8.2 Million in…
Acquisition Represents Forward Integration as a Commercial Organization – EPI Health promotes four prescription products…
Tallinn, Estonia–(Newsfile Corp. – March 11, 2022) – TribeOne is the world’s first decentralized financial…
Fourth Quarter 2021 Total Company Revenue Up 17% to $70.5 Million Compared to Fourth Quarter…
FREMONT, Calif.–(BUSINESS WIRE)–Smart Money Investment Advisors, (SmartMoney IA,) a Silicon-Valley based investment advisory company, has…
New Owners to Launch Major Repositioning of 444-Key Property in Tarrytown, NY Ares Commercial Real…
Project announced in December 2021 will create nearly 500 full-time jobs FRANKFORT, Ky.–(BUSINESS WIRE)–Today, Gov….
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., March 11, 2022 (GLOBE NEWSWIRE) —…
ORION CORPORATION PRESS RELEASE 11 March 2022 at 8.30 EET Orion’s collaboration partner Bayer submits application…
Saint Herblain (France), March 11, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN…
NEW ORLEANS–(BUSINESS WIRE)–ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May…
LONDON, March 11, 2022 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company”…
NEWBURY PARK, Calif.–(BUSINESS WIRE)–Kolibri Global Energy Inc. (TSX: KEI) (OTCQB: KGEIF): All amounts are in…
Company’s principal auditor is located in the United States and is currently inspected by the…
SAN DIEGO, March 10, 2022 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical…